share_log

Insider Sale: 10% Owner at $PASG (PASG) Sells 20,903 Shares

Quiver Quantitative ·  12/06 19:15

ADVISORS LLC ORBIMED, a 10% owner of $PASG ($PASG), sold 20,903 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.3% of their shares. Following this trade, they now own 7,697,466 shares of $PASG stock.

$PASG Insider Trading Activity

$PASG insiders have traded $PASG stock on the open market 9 times in the past 6 months. Of those trades, 3 have been purchases and 6 have been sales.

Here's a breakdown of recent trading of $PASG stock by insiders over the last 6 months:

  • ADVISORS LLC ORBIMED has traded it 6 times. They made 0 purchases and 6 sales, selling 336,534 shares.
  • CAPITAL MANAGEMENT LP LYNX1 has traded it 3 times. They made 3 purchases, buying 456,353 shares and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PASG Hedge Fund Activity

We have seen 17 institutional investors add shares of $PASG stock to their portfolio, and 25 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • VERSANT VENTURE MANAGEMENT, LLC removed 4,026,417 shares (-100.0%) from their portfolio in Q3 2024
  • LYNX1 CAPITAL MANAGEMENT LP added 3,369,326 shares (+66.6%) to their portfolio in Q3 2024
  • MILLENNIUM MANAGEMENT LLC removed 587,067 shares (-78.2%) from their portfolio in Q3 2024
  • ACUITAS INVESTMENTS, LLC removed 471,812 shares (-100.0%) from their portfolio in Q3 2024
  • ORBIMED ADVISORS LLC removed 301,700 shares (-3.0%) from their portfolio in Q3 2024
  • RENAISSANCE TECHNOLOGIES LLC added 267,272 shares (+23.7%) to their portfolio in Q3 2024
  • AFFINITY ASSET ADVISORS, LLC removed 264,266 shares (-100.0%) from their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする